Taixiang Wu

Statistics and Probability · 2010–2015

A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Taixiang Wu trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Douglas G. Altman (in Statistics and Probability)
  2. David Moher (in Statistics and Probability)
  3. K. F. Schulz (in Statistics and Probability)

Papers from Taixiang Wu's perspective

Ordered by how strongly the researchers Taixiang Wu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
  2. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (Annals of Internal Medicine)
  3. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Journal of Pharmacology and Pharmacotherapeutics)
  4. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (Annals of Internal Medicine)
  5. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (British medical journal)
  6. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. (New England Journal of Medicine)
  7. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
  8. Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
  9. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
  10. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)

Their papers